- Home
- SBET vs SLRX Comparison
SBET vs SLRX Comparison
Compare SBET & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- SLRX
- Stock Information
- Founded
- SBET 1995
- SLRX N/A
- Country
- SBET United States
- SLRX United States
- Employees
- SBET N/A
- SLRX N/A
- Industry
- SBET Computer Software: Prepackaged Software
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- SBET Technology
- SLRX Health Care
- Exchange
- SBET Nasdaq
- SLRX Nasdaq
- Market Cap
- SBET 1.8M
- SLRX 1.8M
- IPO Year
- SBET 1997
- SLRX N/A
- Fundamental
- Price
- SBET $40.14
- SLRX $0.72
- Analyst Decision
- SBET
- SLRX
- Analyst Count
- SBET 0
- SLRX 0
- Target Price
- SBET N/A
- SLRX N/A
- AVG Volume (30 Days)
- SBET 5.7M
- SLRX 23.3K
- Earning Date
- SBET 05-15-2025
- SLRX 05-14-2025
- Dividend Yield
- SBET N/A
- SLRX N/A
- EPS Growth
- SBET N/A
- SLRX N/A
- EPS
- SBET N/A
- SLRX N/A
- Revenue
- SBET $3,428,134.00
- SLRX N/A
- Revenue This Year
- SBET N/A
- SLRX N/A
- Revenue Next Year
- SBET N/A
- SLRX N/A
- P/E Ratio
- SBET N/A
- SLRX N/A
- Revenue Growth
- SBET N/A
- SLRX N/A
- 52 Week Low
- SBET $2.26
- SLRX $0.45
- 52 Week High
- SBET $124.12
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- SBET 57.71
- SLRX 41.78
- Support Level
- SBET $45.61
- SLRX $0.68
- Resistance Level
- SBET $82.70
- SLRX $0.80
- Average True Range (ATR)
- SBET 17.07
- SLRX 0.04
- MACD
- SBET 2.08
- SLRX -0.01
- Stochastic Oscillator
- SBET 32.15
- SLRX 8.93
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.